Fig. 2: Immune phenotyping of H&E and survival analysis.

a Examples of patient-level phenotyping based on the corresponding 0.5āmm2 grid phenotyping (top) and thresholding scheme (bottom). KaplanāMeier analysis of progression-free survival based on H&E analysis for primary tumor (b) and pN+ lymph node (c) tissue. IN immune inflamed, ID immune desert, IE immune excluded.